# Andrzej Budaj

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/andrzej-budaj/

## Facts

| Field | Value |
| --- | --- |
| Citations | 75,485 |
| Field | Acute Myocardial Infarction Research |
| h-index | 93 |
| i10-index | 215 |
| Last Known Institution | Çevre, Şehircilik ve İklim Değişikliği Bakanlığı |
| OpenAlex ID | https://openalex.org/A5007198463 |
| ORCID iD | https://orcid.org/0000-0002-6395-2098 |
| Works | 432 |

## Researcher papers

Showing 12 of 17.

- [Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes](https://scholariq.org/papers/ticagrelor-versus-clopidogrel-in-patients-with-acute-coronary-syndromes/)
- [Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology](https://scholariq.org/papers/guidelines-on-the-management-of-valvular-heart-disease-the-task-force-on-the/)
- [ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation](https://scholariq.org/papers/acc-aha-esc-2006-guidelines-for-the-management-of-patients-with-atrial/)
- [2024 ESC Guidelines for the management of chronic coronary syndromes](https://scholariq.org/papers/2024-esc-guidelines-for-the-management-of-chronic-coronary-syndromes/)
- [Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction](https://scholariq.org/papers/long-term-use-of-ticagrelor-in-patients-with-prior-myocardial-infarction/)
- [ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death](https://scholariq.org/papers/acc-aha-esc-2006-guidelines-for-management-of-patients-with-ventricular/)
- [Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)](https://scholariq.org/papers/guidelines-on-diabetes-pre-diabetes-and-cardiovascular-diseases-executive/)
- [A Validated Prediction Model for All Forms of Acute Coronary Syndrome](https://scholariq.org/papers/a-validated-prediction-model-for-all-forms-of-acute-coronary-syndrome/)
- [Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial](https://scholariq.org/papers/renal-outcomes-with-telmisartan-ramipril-or-both-in-people-at-high-vascular-risk/)
- [Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/effect-of-interleukin-1-inhibition-with-canakinumab-on-incident-lung-cancer-in/)
- [Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation](https://scholariq.org/papers/antithrombotic-therapy-after-acute-coronary-syndrome-or-pci-in-atrial/)
- [Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial](https://scholariq.org/papers/relationship-of-c-reactive-protein-reduction-to-cardiovascular-event-reduction/)

## Researcher topics

- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)
- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)

## Researcher university

- [Çevre, Şehircilik ve İklim Değişikliği Bakanlığı](https://scholariq.org/institutions/cevre-sehircilik-ve-iklim-degisikligi-bakanl-g/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.